183 related articles for article (PubMed ID: 1847559)
21. Post-transfusion hepatitis revisited.
Ismay SL; Thomas S; Fellows A; Keller A; Kenrick KG; Archer GT; Wylie BR; Cossart YE
Med J Aust; 1995 Jul; 163(2):74-7. PubMed ID: 7542359
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of hepatitis C in South Africa: detection of anti-HCV in recent and stored serum.
Ellis LA; Brown D; Conradie JD; Paterson A; Sher R; Millo J; Theodossiadou E; Dusheiko GM
J Med Virol; 1990 Dec; 32(4):249-51. PubMed ID: 2127942
[TBL] [Abstract][Full Text] [Related]
23. Predictive markers for hepatitis C antibody ELISA specificity in Australian blood donors.
Hyland CA; Kearns S; Young IF; Battistutta D; Morgan CL
Transfus Med; 1992 Sep; 2(3):207-13. PubMed ID: 1285010
[TBL] [Abstract][Full Text] [Related]
24. [Prevalence of antibodies to hepatitis C (anti HCV) in blood donors in Rio de Janeiro, Brazil. Its relation to ALT and anti HBC].
Leite NC; Nogueira CM; Coelho HS; Perez R; Martins SJ; Soares JA; Junqueira PC
Arq Gastroenterol; 1992; 29(1):5-11. PubMed ID: 1307202
[TBL] [Abstract][Full Text] [Related]
25. [Serum antibodies against hepatitis C: study of 4,100 blood donors from the northeast of France].
Aymard JP; Janot C; Adjizian JC; Tamisier C; Humbert JC; Billuart M; Streiff F
Rev Fr Transfus Hemobiol; 1990 Jul; 33(4):295-302. PubMed ID: 2171543
[TBL] [Abstract][Full Text] [Related]
26. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
[TBL] [Abstract][Full Text] [Related]
27. National blood requirement, serum ALT and hepatitis in Ethiopian blood donors.
Zawde D; Sisay Y
Ethiop Med J; 1991 Oct; 29(4):175-83. PubMed ID: 1659534
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
[TBL] [Abstract][Full Text] [Related]
29. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
Baur P; Roelcke D
Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
31. A comparison of hepatitis C virus (HCV)-RNA and--antibody as markers of infection and predictors of infectivity.
Beardsley AM; LaBrooy JT; Rozen L; Gowans EJ
Aust N Z J Med; 1994 Apr; 24(2):182-7. PubMed ID: 8042947
[TBL] [Abstract][Full Text] [Related]
32. The correlations of surrogate markers with anti-hepatitis C virus and other disease markers.
Myhre BA; Jiminez L; Shitabata P; Ukkestad TS
Ann Clin Lab Sci; 1994; 24(1):76-83. PubMed ID: 7511879
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population.
Mison LM; Young IF; O'Donoghue M; Cowley N; Thorlton N; Hyland CA
Transfusion; 1997 Jan; 37(1):73-8. PubMed ID: 9024493
[TBL] [Abstract][Full Text] [Related]
34. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B and C prevalences among blood donors in the south region of Brazil.
Vasconcelos HC; Yoshida CF; Vanderborght BO; Schatzmayr HG
Mem Inst Oswaldo Cruz; 1994; 89(4):503-7. PubMed ID: 8524053
[TBL] [Abstract][Full Text] [Related]
36. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
37. A study of hepatitis C virus antibodies and serum alanine amino transferase in blood donors in Hong Kong Chinese.
Lin CK; Chu R; Li KB; Leong S
Vox Sang; 1992; 62(2):98-101. PubMed ID: 1325715
[TBL] [Abstract][Full Text] [Related]
38. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
39. Non-A, non-B hepatitis and the anti-HCV assay.
Barbara JA; Contreras M
Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260
[TBL] [Abstract][Full Text] [Related]
40. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients.
Mosley JW; Stevens CE; Aach RD; Hollinger FB; Mimms LT; Solomon LR; Barbosa LH; Nemo GJ
Transfusion; 1995 Jan; 35(1):5-12. PubMed ID: 7998069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
